The second wave of COVID-19 is wreaking havoc in India as it recorded over 1.61 lakh fresh Covid-19 cases in the past 24 hours. It has become the second-largest country to have the highest daily recorded Covid-19 cases after the US.
As a result of the rising daily cases and the states complaining of shortage in the vaccine supply, The Drugs Controller General Of India has given nod to the Sputnik V, making India 60th country to give its approval. Kirill Dmitriev, CEO of the Russian Direct Investment Fund said, “We appreciate the decision of India’s regulatory bodies to grant authorization for Sputnik V…”
This has definitely given a boost to the two country’s ties and is being considered a major milestone as Russia and India has developed extensive cooperation on the Sputnik V trials and also, its local production.
Read Also: New Mexico legalizes cannabis
According to the leading medical journals, THE LANCENT, The Russian vaccine provides full protection against severe cases of Covid-19 and also has an efficacy of 91.6 percent. Before the Sputnik V approval, India is already administering its two vaccines, namely, Covishield ( Serum Institute of India) and Covaxin, developed by Bharat Biotech.
Indeed due to the lax behavior and the various mutants of the Covid -19, the cases have soared up, and thus, it is the duty of not only the government but also of all the public-spirited citizens to abide by all the precautionary measures like wearing masks, following social distancing and maintaining the personal and public hygiene to fight back the pandemic.
Do you want to publish on Apple News, Google News, and more? Join our writing community, improve your writing skills, and be read by hundreds of thousands around the world!
More from World – News Landed
Popular Stories – News Landed